clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02376296 |
P17 | country | United States of America | Q30 |
P582 | end time | 2017-11-01 | |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
Castrate-resistant prostate cancer: the future of antiandrogens | Q56016972 | ||
P2899 | minimum age | 18 | |
P1132 | number of participants | 80 | |
P580 | start time | 2015-02-01 | |
P8363 | study type | observational study | Q818574 |
P1476 | title | Observational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay |
Search more.